News
Dismay but little surprise as NICE rejects Alzheimer's drugs
Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back once again.
News
Gilead's twice-yearly PrEP drug is cleared by FDA
Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
News
Guidance creates access gap in UK for GPP drug Spevigo
People in England and Wales with severe skin disease GPP will soon be able to access a new therapy currently denied to patients in Scotland.
News
Fired ACIP panel says RFK Jr is weakening vaccine programmes
RFK Jr's interference in the ACIP is putting patients at risk, claim the 17 members of the panel abruptly fired last week.
News
UK regulator overhauls medical device regulation
Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
